Principles of Transparency and Best Practice in Scholarly Publishing

Posted in January 11, 2023

Sixteen check list of compliance of the journal to the Principles of Transparency and Best Practice in Scholarly Publishing published January 11, 2023 (joint statement by Committee on Publication Ethics [COPE], Directory of Open Access Journals [DOAJ], the Open Access Scholarly Publishing Association [OASPA], and the World Association of Medical Editors [WAME]; https://doaj.org/apply/transparency) was as follows:

JOURNAL CONTENT	JOURNAL PRACTICES	ORGANISATION	BUSINESS PRACTICES
1. Name of Journal 2. Website 3. Journal Schedule 4. Archiving 5. Copyright 6. Licensing	7. Publication Ethics and Related Editorial Policies 8. Peer Review 9. Access	10. Ownership and Management 11. Advisory Body 12. Editorial Team and Contact Information	13. Author Fees 14. Other Revenue 15. Advertising 16. Direct Marketing

JOURNAL CONTENT

1. Name of journal

The official journal title is Organoid. Abbreviated title is also Organoid.

2. Website

The URL of the official journal website is https://j-organoid.org/. The Organoid managing team endeavors to make a good website. Organoid website demonstrates that care has been taken to ensure high ethical and professional standards. It does not contain any misleading information, including any attempt to mimic another journal/publisher’s site.

3. Journal Schedule

Organoid is online-only journal.

4. Archiving

It is accessible without barrier from Korea Citation Index (https://kci.go.kr) or National Library of Korea (http://nl.go.kr) in the event a journal is no longer published.

5. Copyright

All published papers become the permanent property of the Organoid Society. Copyrights of all published materials are owned by the Organoid Society. Permission must be obtained from the Organoid Society for any commercial use of materials. Every author should sign the copyright transfer agreement forms (https://j-organoid.org/authors/copyright_transfer_agreement.php).

6. Licensing

This is an open-access journal distributed under the terms of the Creative Commons Attribution Non-commercial license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited for non-commercial purpose (http://creativecommons.org/licenses/by-nc/4.0/).

JOURNAL PRACTICES

7. Publication Ethics and Related Editorial Policies

• Organoid follows the Guideline on Good Publication of COPE (https://publicationethics.org) and Recommendations of International Committee of Medical Journal Editors (https://www.icmje.org/recommendations).
  
  
• Our publication ethics and related editorial policies are displayed on the Research and Publication Ethics tab (https://j-organoid.org/policy) and Instruction for Authors (Editorial Policy) tab (https://j-organoid.org/policy) of the journal website.
  
  
• The Editorial Board of Organoid carefully examines whether all submitted manuscripts abide the ethical guidelines of ICMJE and COPE. The published articles should include the statements of conflict of interest, author's contribution, Institutional Review Board, informed consent, and human/animal rights.
  
  
• When the journal faces suspected cases of research and publication misconduct such as a redundant (duplicate) publication, plagiarism, fabricated data, changes in authorship, undisclosed conflicts of interest, an ethical problem discovered with the submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and other issues, the resolving process will follow the flowchart provided by COPE (https://publicationethics.org/resources/flowcharts). The Editorial Board of Organoid will discuss the suspected cases and reach a decision. Organoid will not hesitate to publish errata, corrigenda, clarifications, retractions, and apologies when needed.
  
  

8. Peer Review

• Organoid has an online submission and peer review system at https://submit.j-organoid.org/.
• If the manuscript does not fit the aims and scope of the Journal or does not adhere to the Instructions for Authors, it may be returned to the author immediately after receipt and without a review. Before reviewing, all submitted manuscripts are inspected through a Similarity Check powered by iThenticate, a plagiarism-screening tool. If too high a degree of similarity is found, the Editorial Board will conduct a more detailed content screening.
• Type of peer review: Double-blind review
  
  
• Method of peer review
  
• All submitted manuscripts are screened for duplication through Crosscheck (https://app.ithenticate.com) before review. A manuscript is reviewed for its format and adherence to the aims and scope of the journal. If the manuscript meets these two criteria, it is dispatched to three investigators in the field with relevant knowledge.
• Organoid adopts double blind review, which means that the reviewers and authors cannot identify each others’ information. The authors’ names and affiliations are removed during peer review.
• Assuming the manuscript is sent to reviewers, Organoid waits to receive opinions from at least two reviewers. In addition, if deemed necessary, a review of statistics may be requested. The acceptance criteria for all papers are based on the quality and originality of the research and its scientific significance. Acceptance of the manuscript is decided based on the critiques and recommended decision of the reviewers.
• An initial decision will normally be made within 4 weeks of receipt of a manuscript, and the reviewers’ comments are sent to the corresponding author by e-mail. The corresponding author must indicate the alterations that have been made in response to the reviewers’ comments item by item. Failure to resubmit the revised manuscript within 4 weeks of the editorial decision is regarded as a withdrawal. A final decision on acceptance/rejection for publication is forwarded to the corresponding author from the editor.
• All manuscripts from editors, employees, or members of the editorial board are processed same to other unsolicited manuscripts. During the review process, submitters will not engage in the decision process. Editors will not handle their own manuscripts although they are commissioned ones.
• We neither guarantee the acceptance without review nor very short peer review times for unsolicited manuscripts. Commissioned manuscripts also reviewed before publication.

9. Access

Organoid is an open access journal. A free full-text service, both in XML and PDF formats, is available immediately upon publication without an embargo period.

ORGANISATION

10. Ownership and Management

This journal is owned by the publisher, the Organoid Society (https://www.organoids.org). The journal is managed by the Management Team.

11. Advisory Body

The advisory body is the journal's editorial board. The full names and affiliations of the journal’s editors are displayed on the About (Editorial Board) tab of the journal website.

12. Editorial Team and Contact Information

Editorial team is available from Editorial Board page at the front part of the journal.

Contact information
Room 319, Hall 1 of Chonbuk National University Dental College, 20, Geonji-ro, Deokjin-gu, Jeonju 54907, Korea
Tel: +82-63-270-4024
E-mail: editor@j-organoid.org

BUSINESS PRACTICES

13. Author Fees

Neither page charge, article processing fee nor submission fee will be applied. Organoid is a platinum open access journal, meaning there are no fees on the author side.

14. Other Revenue

Revenue sources of journal were from the support of publisher (the Organoid Society), and advertising rates.

15. Advertising

Organoid accepts advertising and sponsorship for its journal according to the following principles:
• Advertising is separate from content. Advertisers and sponsors have no advance knowledge of our editorial contents, nor do the editors have advance knowledge of advertisers. Content is never altered, added, or deleted to accommodate advertising. Advertisers and sponsors have no input regarding any of our editorial decisions or advertising policies.
• We reserve the right to decline or cancel any advertisement at any time.
• Advertisements for pharmaceutical products must conform to all regulations and policies of the Ministry of Food and Drug Safety, Republic of Korea in every respect.

16. Direct marketing

Journal propagation has been done through the journal web site and distribution of an introduction pamphlet. Invitations to submit a manuscript are usually focused on the presenters at conferences, seminars, or workshops if the topic is related to the journal's aims and scope.